Global collaboration for vaccine discovery: A novel approach to combat HIV
Dr. Leo Stamatatos of Seattle Biomedical Research Institute explains how researchers hope to fight the global HIV pandemic
The 2006-07 season of the Seattle Science & Technology Discovery Series concluded on June 8th with a presentation by Dr. Leo Stamatatos, principal investigator and director of the Viral Vaccines Program at Seattle Biomedical Research Institute.
Dr. Stamatatos explained the magnitude of the HIV pandemic and the challenges that researchers face in developing a vaccine for the virus, which, unlike many other viruses for which we vaccinate people, is constantly changing. He also shared with Discovery Series members how SBRI is partnering with other research organizations around the world on the development of an HIV vaccine. Backed by the Bill & Melinda Gates Foundation, this innovative collaboration employs rapid data-sharing and new methods, such as computer modeling for vaccine design, with the ambitious goal of finding a vaccine solution to the scourge of HIV within five years.
Did you know...?
Thank you to our members and sponsors for another great season of science and technology for breakfast. See you in September!
2007-08 season preview:
September 14: Dr. Mark Roth, cell biologist at Fred Hutchinson Cancer Research Center, on human hibernation.
October 12: Tom Vander Ark, president of the X Prize Foundation, on revolution through competition.
December 14: Dr. Chris Elias, president of PATH, on programs to advance global health.
Registration information for the 2007-08 season will be sent out shortly. Watch for it in your inbox!
The Science & Technology Discovery Series in Seattle is sponsored by:
AH&T, Inc., Perkins Coie, and Swedish Medical Center.
The 2006-07 season of the Seattle Science & Technology Discovery Series concluded on June 8th with a presentation by Dr. Leo Stamatatos, principal investigator and director of the Viral Vaccines Program at Seattle Biomedical Research Institute.
Dr. Stamatatos explained the magnitude of the HIV pandemic and the challenges that researchers face in developing a vaccine for the virus, which, unlike many other viruses for which we vaccinate people, is constantly changing. He also shared with Discovery Series members how SBRI is partnering with other research organizations around the world on the development of an HIV vaccine. Backed by the Bill & Melinda Gates Foundation, this innovative collaboration employs rapid data-sharing and new methods, such as computer modeling for vaccine design, with the ambitious goal of finding a vaccine solution to the scourge of HIV within five years.Did you know...?
- Approximately 40 million people worldwide are living with HIV, more than half of those in sub-Saharan Africa.
- Last year, more than 4 million new cases of HIV were diagnosed, at a rate of 11,000 infections per day.
- There are 2 types of vaccines that researchers are working on to combat HIV: neutralizing antibodies (which prevent infection from occurring) and “killer” T-cells (which target and eliminate infected cells).
Thank you to our members and sponsors for another great season of science and technology for breakfast. See you in September!
2007-08 season preview:
September 14: Dr. Mark Roth, cell biologist at Fred Hutchinson Cancer Research Center, on human hibernation.
October 12: Tom Vander Ark, president of the X Prize Foundation, on revolution through competition.
December 14: Dr. Chris Elias, president of PATH, on programs to advance global health.
Registration information for the 2007-08 season will be sent out shortly. Watch for it in your inbox!
The Science & Technology Discovery Series in Seattle is sponsored by:
AH&T, Inc., Perkins Coie, and Swedish Medical Center.
Labels: AIDS, Dr. Leo Stamatatos, HIV, pandemic, SBRI, vaccine
0 Comments:
Post a Comment
Links to this post:
Create a Link
<< Home